Tumore in generale
Bibliografia

  1. Kidd,P.M. “The Use of Mushroom Glucans and Proteoglycans in Cancer Therapy.” Altern Med Rev 5(2000):4-27.
  2. Kondo,M., et al.”Evaluation of an Anticancer Activity of a Protein-bound Polysaccharide PSK(Krestin).” In Torisu, M., and T.Yoshida (eds.)Basic Mechanisms and Clinical Treatment of Tumour Metastasis. New York : Academic Press,1985,pp.623-636.
  3. Lau,C.B.,et al.”Cytotoxic Activities of Coriolus versicolor (Yungzhi) Extract on Human Leukemia and Lymphoma Cells by Induction of Apoptosis.”Life Sci 75:7(2004):797-808.
  4. Cancer Research UK. “Medicinal Mushrooms and Cancer.” Available online at: http://www.sci.cancerresearchuk.org./ labs/ medmush/ medmush.html.
  5. Ikekawa,T., et al.”Anti-tumor Activity of Aqueous Extracts of Edible Mushrooms.”Cancer Res 29(1969): 743-735.
  6. Fujimiya Y., et al. “Peroral Effect on Tumour Progression of Soluble Beta-(1,6)-glucans Prepared by Acid Treatment from Agaricus blazei. Murr. (Agaricaceae, Higher Basidiomycetes)” Int J Med Mushr2(2000): 43-49.
  7. Ikusawa T., et al., “Fate and Distribution of an Anti-tumour Protein-bound Polysaccharide PSK (Krestin).” Int J Immunopharmacol 10 (1988):415-423.
  8. Ito H., et al. “Anti-tumor Effects of a New Polysaccharide-protein Complex (ATOM) Prepared fom Agaricus blazei (Iwade Strain 101) and its Mechanisms in Tumor-bearing Mice.” Anticancer Res 17(1997):277-284
  9. Mizuno T., et al: “Antitumor Activity and Some Properties of Water-soluble Polysaccharides from”Himematsutake,”the Fruiting Body of Agaricus blazei Murrill.” Agr Biol Chem(Tokyo)54(1990):2889-2896.
  10. Mizuno T. et al. “Anti-tumor Polysaccharide from the Mycelium of Liquid cultured Agaricus blazei Mill.” Biochem Mol Biol Int 47:4(1999):707-714.
  11. Ohno,N., et al. “Antitumor Beta-glucan from the Cultured Fruit-body of Agaricus blazei.” Biol Pharm Bull 24:7(2001):820-828
  12. Takaku,T.,et al. “Isolation of an Antitumor Compound from Agaricus blazei Murrill and Its Mechanism of Action.” J Nutr 131:5(2001):1409-1413
  13. Liu J.X., et al. “Phase III Clinical Trial for Yun Zhi  Polysaccharopeptide (PSP) Capsules.” In Yang, Q. Y. (ed). Advanced Research in PSP. Hong Kong: Hong Kong Association for Health Care, 1999, pp. 295-303.
    14.Liu L.F. “PSP in Clinical Cancer Therapy. “In Yang, Q. Y. (ed). Advanced Research in PSP. Hong Kong: Hong Kong Association for Health Care, 1999, pp. 68-75.
    15.  Mao X.W., et al. “Effects of Extract of Coriolus versicolor and IL-2 on Radiation Against Three Tumor Lines.” Lorna Linda University, unpublished data,1998.
    16.  McCune, C.S., et al. “Basic Concepts of Tumour Immunology and Principles of Immunotherapy. ” In Clinical Oncology, 7th  edition. Philadelphia : W. B. Saunders, 1993, p.123.
    17.  Ito M., et al. “Anti-tumor Activity of Hot-water Extract of Hericium erinaceus (Yamabushitake).” Nature Med 53(1999):263-265.

Tumore Immunoterapia
Bibliografia               

  1. Fujimoto,S.,et al.”Clinical Value of Immunochemotherapy with OK-32.” Jpn J Surg 3 (1979): 190-196.
  2. Kodama, N., et al. “Can Maitake MD-fraction Aid Cancer Patients?” Alt Med Rev 7:3 (2002): 236-239.
  3. Qian, Z.M., et al. “Polysaccharide Peptide (PSP) Restores Immunosuppression Induced by Cyclophosphamide.” In Yang, Q. Y. (ed.) Advanced Research in PSP. Hong Kong Association for Health Care, 1999; PP.154-163.
  4. Reshetnikov, S.C., et al. “Higher Basidiomycetes as a Source of Antitumour and Immunostimulating Polysaccharides.” Int J Med Mushr 3 (2001): 361-394.
  5. Sakagami,H., et al. “Induction of Immunopotentiation Activity by a Proteinbound Polysaccharide, PSK.” Anticancer Res 11(1991):993-1000.
  6. Wang,S.Y., et al. “The Anti-tumor Ganoderma lucidum is Mediated by Cytokines Released from Activated Macrophages and T Lymphocytes.” Int J Cancer 70 (1997): 699-705.
  7. Wang,J.C., et al. “Antitumor and Immunoenhancing Activities of Polysaccharide from Culture Broth of Hericium spp.” Kaohsiung J Med Sci 17:9 (2001): 461-467.
  8. Xu,H.M., et al. “Immunomodulatory Function of Polysaccharide of Hericium erinaceus.” Chung kuo chung his I chieh ho tsa chih 14(1994):427-428.

Tumore Citotossicità
Bibliografia

  1. Kodama,N.; A.Asakawa, A.Inui, et al. “Enhacement of Cytotoxicity of NK Cells by D-fraction, a Polysaccharide from Grifola frondosa.”Oncol Rep 13:3 (2005):497-502.
  2. Fujimiya,Y.,et al. “Selective Tumoricidal Effect of Soluble Proteoglucan Extracted from the Basidiomycete, Agaricus blazei Murill, Mediated via Natural Killer Cell Activation and Apoptosis.” Cancer Immunol Immunother 46 (1998): 147-159
  3. Fujimiya,Y., et al.”Tumor-specific Cytocidal and Immunopotentiating Effects of Relatively Low Molecular Weight Products Derived from the Basidiomycete, Agaricus blazei Murill.”Anticancer Res 19 (1999): 113-118.
  4. Dong,Y., et al.”In vitro Inhibition of Proliferation of HL-60 Cells by Tetrandrine and Peptides Derived from Chinese Medicinal Herbs.”Life Sci 60 (1997): 135-140.
  5. Stephens,L.C.,et al.”Apoptosis in Irradiated Murine Tumours.”Radiation Res 127 (1991): 308.

Tumore e Angiogenesi  
Bibliografia

  1. Kimura,Y., et al.”Isulation of an Anti-angiogenic Substance from Agaricus blazei Murrill:Its Antitumor and Antimetastatic Actions.”Cancer Sci 95:9 (2004):758-764 

Tumore Chemio Radiazioni e Chirurgia e Funghi
Bibliografia   

  1. Kaibarara,N.,et al. “Postoperative Long-term Chemotherapy for Advanced Gastric Cancer. “Jpn J Surg6(1976): 54-59.
  2. Kim,K.C.,et al.”Ganoderma lucidum Extracts Protect DNA from Strand Breakage Caused by Hydroxyl Radical and UV Irradiation.”Int J Mol Med 4 (1999): 273-277.
  3. Lino,Y.,et al. “Immunochemotherapies vs. Chemotherapy as Adjuvant Treatment after Curative Resection of Operable Breast Cancer.” Anticancer Res 15 (1995): 2907-2912.
  4. Morimoto,T.,et al.”Postoperative Adjuvant Randomised Trial Comparing Chemoendocrine Therapy, Chemotherapy and Immunotherapy for Patients with Stage II Breast Cancer:5-year Results from the Nishimihou Cooperative Study Group of of Adjuvant Chemoendocrine Therapy for Breast Cancer(ACETBC) of Japan.” Eur J Cancer 32A (1996): 235-242.
  5. Nakazato,H.,et al.”Efficacy of Immunochemotherapy as Adjuvant Treatment after Curative Resection of Gastric Cancer.” Lancet 343(1994): 1122-1126.
  6. Shiu,W.C.T.,et al.”A Clinical Study of PSP on Peripheral Blood Counts During Chemotherapy.” Physiol Res 6(1992):217-218.
  7. Sun,Z.,et al. “The Ameliorative Effect of PSP on the Toxic and Side Reaction of Chemo-and Radiotherapy of Cancer. ” In Yang, Q.Y. (ed): Advanced Research in PSP.Hong Kong Association for Health Care, 1999
  8. Toi,M.,et al. “Randomised Adjuvant Trial to Evaluate the Addition of Tamoxifen and PSK to Chemotherapy in Patients with Primary Breast Cancer.” Cancer 70(1992):2475-2483.
  9. Tsang,K.W.,et al. ” Coriolus versicolor Polysaccharide Peptide Slows Progression of Advanced Non-small Cell Lung Cancer.” Resp Med 97:6(2003):618-624
  10.  Tsujitani,S.,et al. “Postoperative Adjuvant Immunochemotherapy and Infilitration of Dendritic Cells for Patients with Advanced Gastric Cancer.” Anticancer Res 12(1992):645-648.
  11.  Tsukagoshi,S.,et al.”Krestin(PSK).”Cancer Trat Rev 11(1984): 131-155.

Tumore Esofageo
Bibliografia

  1. Okazaki,M.,et al. “Structure-activity Relationship o(1-3)-(-D-glucan in the Induction of Cytokine Production from Macrophages in vitro.”Biol Pharmacol Bull 18(1995):1320-1327.
  2. Yao,W. “Prospective Randomised Trial of Radiotherapy Plus PSP in the  Treatment of Oseophageal Carcinoma.” In Yang, Q.Y. (ed.).Advanced Research in PSP. Hong Kong: Hong Kong Association for Health Care, 1999, pp.310-313.

Tumore Polmonare
Bibliografia

  1. Hayakawa,K.,et al. “Effect of Krestin (PSK) as Adjuvant Treatment on the Prognosis after Radical Radiotherapy in Patients with Non-small Cell Lung Cancer.” Anticancer Res 13 (1993): 1815-1820.
  2. Tsang K.W., et al. “Coriolus versicolor Polysaccharide Peptide Slows Progression of Advanced Non-small Cell Lung Cancer.” Resp Med 97:6(2003):618-624

Tumore Seno
Bibliografia  

  1. Lu,Q.Y.,et al.”Ganoderma lucidum Spore Extract Inhibits Endothelial and Breast Cancer Cells in vitro.”Oncol Rep 12:3(2004):659-662.
  2. Morimoto,T.,et al.”Postoperative Adjuvant Randomised Trial Comparing Chemoendocrine Therapy, Chemotherapy and Immunotherapy for Patients with Stage II Breast Cancer:5-year Results from the Nishimihou Cooperative Study Group of of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan.”Eur J Cancer 32A (1996):235-242.
  3. Sugimachi, K., et al.”Hormone Conditional Cancer Chemotherapy for Recurrent Breast Cancer Prolongs Survival.”Jpn J Surg14 (1994):217-221.
  4. Yokoe,T.,et al. “HLA Antigen as Predictive Index for the Outcome of Breast Cancer Patients with Adjuvant Immunochemotherapy with PSK.” Anticancer Res 17(1997): 2815-2818.

Tumore Vescica
Bibliografia

  1. Lu,Q.Y., et al.”Ganoderma lucidum Extracts Inhibit Growth and Induce Actin Polymerization in Bladder Cancer in vitro.”Cancer Lett 216:1 (2004) : 9-20.

Lascia una risposta

Il tuo indirizzo mail non sarà pubblicato.

Immagine CAPTCHA

*